Literature DB >> 21840616

Glycated haemoglobin: what is the diagnostic yield at shortened testing intervals?

Tze Ping Loh1, Karen Mei Ling Tan, Sharon Saw, Sunil Kumar Sethi.   

Abstract

The proportion of sequential HbA1c exceeding critical difference (diagnostic yield), where it is considered clinically significant change, was calculated for different testing intervals. 12% and 26% of repeat HbA1c exceeded the critical difference before 30 and 90 days testing intervals, respectively. Repeating HbA1c within 4 weeks has poor diagnostic yield and should be avoided.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840616     DOI: 10.1016/j.diabres.2011.07.034

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  Development of a clinical decision support system for diabetes care: A pilot study.

Authors:  Livvi Li Wei Sim; Kenneth Hon Kim Ban; Tin Wee Tan; Sunil Kumar Sethi; Tze Ping Loh
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

2.  Effect of ranolazine on glycaemia in adults with and without diabetes: a meta-analysis of randomised controlled trials.

Authors:  Ik Hur Teoh; Moulinath Banerjee
Journal:  Open Heart       Date:  2018-12-20

3.  Effectiveness of Color Coded Diabetic Control Monitoring Charts among Elderly Diabetics Attending Outreach Primary Care Geriatric Clinics in Rural Karnataka: An Open Label Randomized Control Trial.

Authors:  Farah N Fathima; Neethu George; Meera George; Savan Sara Mathew; M Rajitha; Twinkle Agrawal; Arvind Kasturi
Journal:  Indian J Community Med       Date:  2019 Jan-Mar

4.  Timings for HbA1c testing in people with diabetes are associated with incentive payments: an analysis of UK primary care data.

Authors:  J A Hirst; A J Farmer; M C Smith; R J Stevens
Journal:  Diabet Med       Date:  2018-09-21       Impact factor: 4.359

5.  Changes in HbA1c level over a 12-week follow-up in patients with type 2 diabetes following a medication change.

Authors:  Jennifer A Hirst; Richard J Stevens; Andrew J Farmer
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.